Mannkind corp (MNKD)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-46,342

-51,903

-47,391

-61,185

-71,473

-86,975

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

134,213

-

-205,329

-363,707

-362,660

-368,445

-127,867

-132,529

-176,984

-198,382

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of commitment asset

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

6,332

6,203

6,454

6,377

5,913

6,857

6,799

6,483

5,523

4,847

4,768

5,023

5,129

5,135

6,477

7,575

7,995

8,725

8,245

817

39,688

48,622

0

0

0

Depreciation, amortization and accretion

1,143

972

775

2,137

2,518

2,857

3,310

3,200

3,326

3,528

3,768

3,887

4,043

4,158

6,279

8,975

11,311

13,276

13,095

12,320

12,169

18,575

0

0

0

(Gain) loss on extinguishment of debt

-

-

-

-

-

-765

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of right-of-use assets

1,069

1,182

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest on note payable to principal stockholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Gain on foreign currency translation

1,774

1,913

5,856

2,777

9,387

4,468

1,543

-2,870

-15,080

-13,641

-5,609

-2,936

4,252

3,433

0

0

0

-

-

-

-

-

-

-

-

Interest expense on promissory notes

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest incurred through borrowings under Sanofi Loan Facility

-

-

-

-

-

-

-

-

-

-

-

-

-

4,478

4,979

3,991

2,787

1,652

0

0

0

-

-

-

-

Interest on note payable to related party

-

-

-

-

-

-

-

4,566

4,190

3,782

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of inventory

496

0

420

1,433

1,610

2,212

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

0

-

-

-

41

35

0

0

0

-

-

-

-

-19

0

0

0

-

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

1,415

-504

1,341

2,126

2,209

1,339

1,059

1,647

1,223

2,487

-1,310

1,335

317

302

0

0

0

-

-

-

-

-

-

-

-

Receivable from Sanofi

-

-

-

-

-

-

-

-

-

-30,557

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

7

558

1,327

1,720

1,439

3,152

2,626

2,794

3,766

3,297

0

0

0

-

-

-

-

26,434

0

0

0

-

-

-

-

Receivable from collaboration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Deferred costs from commercial product sales

-

-

-

-

-

-

-

-

-

96

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred costs from collaboration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,539

0

0

0

-

-

-

-

Prepaid expenses and other current assets

-491

333

569

136

38

-454

-46

6

-1,154

-1,354

-1,473

1,141

701

346

-5,986

-9,946

-10,861

-13,481

-7,013

10,393

12,748

14,734

0

0

0

Right-of-use and other assets

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

0

-

-

-

0

-

-

-

-

-188

-220

-724

-486

-361

-1,129

-778

-936

-150

392

1,185

1,405

615

0

0

0

Accounts payable

-250

-593

5,846

-1,704

2,002

-1,605

532

2,696

3,457

3,800

269

3,771

1,016

-12,118

823

-1,883

-2,204

8,413

-12,768

-181

478

3,622

0

0

0

Accrued expenses and other current liabilities

3,042

3,498

1,555

1,891

1,910

2,249

603

4,233

4,530

2,932

-3,338

-2,798

937

348

30

-2,004

-1,319

-12,467

-643

-2,209

-1,680

2,276

0

0

0

Deferred revenue

-15,638

-6,717

22,110

37,970

47,563

46,814

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Recognized loss on purchase commitments

-

-4,395

-5,169

-5,123

-8,755

-6,939

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

0

0

-

-

-

-

Deferred payments from collaborations

-

-

-

-

-

-

-

-

-

-

0

0

-134,296

-

0

0

0

-

-

-

-

-

-

-

-

Recognized loss on purchase commitments

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Milestone rights liability and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,384

17

21

0

0

0

Net cash (used in) provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-38,825

-

-87,889

-84,710

-91,010

-57,232

-70,425

49,705

44,096

4,086

0

0

0

Net cash used in operating activities

-88,105

-88,483

-58,388

-20,256

-27,678

-37,731

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

2,446

2,565

0

0

0

-

-

-

-

-

-

-

-

1,144

1,460

2,692

7,226

10,285

14,932

23,167

26,891

24,097

0

0

0

Purchase of treasury bills

-

44,971

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of treasury bills

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from sale of asset held for sale

-

-

-

-

-

-

-

-

-

16,651

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

17

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

22,040

-22,843

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,606

-7,940

-1,555

4,146

0

0

0

-

-

0

0

Milestone payment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,219

0

0

0

-

-

-

-

Exercise of stock options

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of employment taxes related to vested restricted stock units

0

-

-

-

-

-

201

223

133

127

114

250

237

165

186

1,043

1,099

1,858

1,897

27,603

27,637

26,908

0

0

0

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

16,651

-

-1,439

-2,593

-7,127

-10,203

-24,104

-23,167

-26,891

-24,097

0

0

0

Other

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

42,499

-

91,930

43,849

4,946

5,668

-45,008

39,435

67,880

70,062

0

0

0

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

70,192

69,864

100,789

33,471

60,769

61,294

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

4,127

-41,462

19,516

-13,421

7,824

23,329

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET DECREASE IN CASH AND CASH EQUIVALENTS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-93,191

-

-139,537

65,973

85,085

50,051

0

0

0

SUPPLEMENTAL CASH FLOWS DISCLOSURES:
Interest paid in cash, net of amounts capitalized

0

-

-

-

-

3,759

4,250

5,447

7,038

7,728

8,166

8,524

8,828

8,991

0

0

0

-

-

-

-

-

-

-

-

Interest paid in cash, net of amounts capitalized to construction in progress

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,289

11,218

0

0

0

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issuance to settle employee stock purchase plan liability

657

656

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tranche B Commitment Asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Payment of senior convertible notes through common stock issuance

-

-

-

-

-

5,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment of interest on senior convertible notes through common stock issuance

685

1,075

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash construction in progress and property and equipment

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Addition of right-of-use assets upon adoption of new lease guidance

-

5,192

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of note payable to related party through common stock issuance

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued but unpaid debt issuance costs

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash construction in progress and property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-1,849

-574

1,162

1,768

0

0

0

At The Market Issuance
Proceeds from at-the-market offering

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock pursuant to at-the-market offering

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance costs associated with at-the-market offering

0

-

-

-

-

84

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-